You are here » Companies » Company Overview » Divis Laboratories Ltd
Divis Laboratories Ltd.
BSE: 532488 | Sector: Health care |
NSE: DIVISLAB | ISIN Code: INE361B01024 |
BSE 00:00 | 24 Apr | Divis Laboratories Ltd |
NSE 05:30 | 01 Jan | Divis Laboratories Ltd |
OPEN | 2377.00 |
PREVIOUS CLOSE | 2421.75 |
VOLUME | 24549 |
52-Week high | 2473.65 |
52-Week low | 1466.95 |
P/E | 50.76 |
Mkt Cap.(Rs cr) | 64,469 |
Buy Price | 2415.00 |
Buy Qty | 2.00 |
Sell Price | 2445.00 |
Sell Qty | 3.00 |
Divis Laboratories Ltd. (DIVISLAB) - BULK/BLOCK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
30-11-2018 |
INTEGRATED CORE STRATEGIES (ASIA) P TE.LTD. |
NSE | SELL | 1886001 | 1438.98 |
31-05-2018 |
BLACKROCK INDIA EQUITIES FUND (MAUR ITIUS) LIMITED |
NSE | SELL | 1454375 | 1047.17 |
31-05-2017 |
INTEGRATED CORE STRATEGIES (ASIA) P TE.LTD. |
NSE | BUY | 2285198 | 582.12 |
31-05-2017 |
BARCLAYS GLOBAL FUND ADVISORS A/C I SHARES INDIA MAURITIUS C |
NSE | SELL | 2373622 | 582.90 |
30-11-2012 |
VANGUARD EMERGING MARKETS STOCK IND EX FUND A SERIES OF VANG |
NSE | BUY | 955020 | 1194.11 |
30-11-2012 |
VANGUARD EMERGING MARKETS STOCK IND EX FUND A SERIES OF VANG |
NSE | BUY | 955020 | 1194.11 |
24-09-2008 |
DEUTSCHE SECURITIES MAURITIUS LIMIT ED |
NSE | BUY | 2160000 | 1397.00 |
24-09-2008 |
MERRILL LYNCH CAPITAL MARKETS ESPAN A S.A. SVB |
NSE | SELL | 2160000 | 1397.00 |
22-05-2007 |
MERRILL LYNCH CAPITAL MARKETS ESPAN A S.A. S.V. |
BSE | BUY | 67649 | 3939.93 |
Quick Links for Divis Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices